Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rituximab - Immunotherapy for Schizophrenia Spectrum Disorder in Adults: An Open Pilot Study

NCT03983018 is registered in ClinicalTrials.gov with Region Örebro County as lead sponsor.

NCT NCT03983018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03983018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rituximab - Immunotherapy for Schizophrenia Spectrum Disorder in Adults: An Open Pilot Study
Lead sponsor
Region Örebro County
Phase
Phase 2
Overall status
Completed
Start date
August 7, 2019
Completion date
March 31, 2022
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia spectrum and other psychotic disorders, treatment-resistant schizophrenia